Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
PTC Therapeutics
Scientific Title
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma